- ￥6768
- AntibodySystem
- 468.75 - 30,000 ng/mL
- 329.66 ng/mL
- France
- KDB94402
- 2025年12月21日
9 年钻石会员
企业认证
相关产品推荐更多 >
大鼠β2微球蛋白(BMG/β2-MG)酶联免疫吸附测定试剂盒 | Rat BMG/β2-MG(Beta-2-Microglobulin) ELISA Kit
￥2300
Anti-MPXV H3L Human IgG ELISA Kit（ELISA试剂盒）
￥3700Anti-CHIKV NSP1 hIgG ELISA Kit（ELISA试剂盒）
￥6768
人成纤维细胞生长因子18(FGF18)酶联免疫吸附测定试剂盒 | Human FGF18 (Fibroblast Growth Factor 18) ELISA Kit
￥2100
未包被人半乳凝集素3(GAL3)酶联免疫吸附测定试剂盒 | Uncoated Human GAL3(Galectin 3) ELISA Kit
￥5200
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 供应商：
武汉益普生物科技有限公司
- 检测范围：
468.75 - 30,000 ng/mL
- 检测方法：
Colorimetric
- 样本：
Plasma, Serum
- 灵敏度：
329.66 ng/mL
- 规格：
96T
| 产品名 | Certolizumab ELISA Kit |
| 货号 | KDB94402 |
| 规格 | 96T |
| 别名 | CDP870, PHA-738144, Certolizumab pegol, CAS: 428863-50-7 |
| 应用 | Used for the quantitative determination of Certolizumab concentration in serum and plasma. |
| 检测方法 | Colorimetric |
| 样本类型 | Plasma, Serum |
| 实验类型 | Quantitative |
| 检测范围 | 468.75 - 30,000 ng/mL |
| 灵敏度 | 329.66 ng/mL |
| 回收率 | 80-120% |
| 精准度 | CV<20% |
| 描述 | PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human TNFa has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Certolizumab in the sample competitively binds to the pre-coated protein with biotin-labeled Certolizumab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Certolizumab bound in the initial step. The color development is stopped and the intensity of the color is measured. |
| 背景 | Certolizumab pegol is a recombinant, humanized F(ab)’ fragment of an antibody conjugated to polyethylene glycol to enhance its plasma half-life. It does not contain an FC region and therefore does not cause antibody-dependent cell-mediated or complement-dependent cytotoxicity as described for infliximab, etanercept, and adalimumab. Another difference is that certolizumab pegol preferentially penetrates inflamed tissue compared to noninflamed tissue, and does so to a greater extent than adalimumab or infliximab. It is directed against soluble and membrane-associated human TNF-α and was approved for the treatment of Crohn’s disease that does not respond to conventional therapy in 2008 and for RA in 2009. |
| 稳定性和存储 | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20 ℃, the rest reagents should be store at 4℃. |
| 保存方法 | 2-8 ℃ |
| 说明 | For Research Use Only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
Certolizumab ELISA Kit（ELISA试剂盒）
￥6768
